HSIC
44
5
RCL
64
2
CNX
34
-2
AZO
52
2
FRT
41
5
VRTX
65
-3
TDC
55
-4
INTC
44
-9
KR
53
5
C
39
2
GOOGL
59
-7
STI
1
-33
ABT
50
2
GE
67
2
AMGN
47
6
MRK
58
2
O
39
2
VZ
24
5
SJM
36
2
CRM
49
2
HSIC
44
5
RCL
64
2
CNX
34
-2
AZO
52
2
FRT
41
5
VRTX
65
-3
TDC
55
-4
INTC
44
-9
KR
53
5
C
39
2
GOOGL
59
-7
STI
1
-33
ABT
50
2
GE
67
2
AMGN
47
6
MRK
58
2
O
39
2
VZ
24
5
SJM
36
2
CRM
49
2
Financhill
Back

ICL Group Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
25

ICL
ICL Group

Last Price:
4.39
Seasonality Move:
-0.51%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
38.01
Seasonality Move:
3.65%
Sell
25
ICL Group (ICL) is a Sell

Is ICL Group a Buy, Sell or Hold?

  • The current ICL Group [ICL] share price is $4.44. The Score for ICL is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • ICL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ICL Stock Price Chart

What is ICL Group's stock price today?

  • The ICL Group share price today is $4.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ICL is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

ICL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 38.03 Sell
Chaikin Money Flow: 390002 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.54 - 4.8) Sell
Bollinger Bands (100): (4.58 - 5.14) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

ICL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.51 Sell
20-day SMA: 4.65 Sell
50-day SMA: 4.71 Sell
200-day SMA: 5.01 Sell
8-day EMA: 4.51 Sell
20-day EMA: 4.6 Sell
50-day EMA: 4.72 Sell
200-day EMA: 5.15 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

ICL Group Earnings Growth & ICL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.17 per share, and an increase next year of $0.10 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

ICL Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):